Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines

被引:22
作者
Albert, Helene [1 ]
Battaglia, Eric [1 ]
Monteiro, Carolino [2 ]
Bagrel, Denyse [1 ]
机构
[1] Univ Lorraine, LIMBP SRSMC, EA 3940, F-57070 Metz, France
[2] Univ Lisbon, Fac Farm, P-1699 Lisbon, Portugal
来源
MOLECULAR ONCOLOGY | 2012年 / 6卷 / 05期
关键词
CDC25; phosphatases; Alternative splicing; Genotoxic stress; Breast cancer cells; DNA-DAMAGE; DIFFERENTIAL EXPRESSION; P53; VARIANTS; PROTEIN; CYCLE; OVEREXPRESSION; DEGRADATION; MECHANISMS; RESISTANCE;
D O I
10.1016/j.molonc.2012.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CDC25 (cell division cycle 25) phosphatases are essential for cell cycle control under normal conditions and in response to DNA damage. They are represented by three isoforms, CDC25A, B and C, each of them being submitted to an alternative splicing mechanism. Alternative splicing of many genes is affected in response to genotoxic stress, but the impact of such a stress on CDC25 splicing has never been investigated. In this study, we demonstrate that genotoxic agents (doxorubicin, camptothecin, etoposide and cisplatin), alter the balance between CDC25C splice variants in human breast cancer cell lines both at the mRNA and protein levels. This modulation occurs during the response to moderate, sub-lethal DNA damage. Our results also suggest that the CDC25C splice variants expression shift induced by a genotoxic stress is dependent on the ATM/ATR signaling but not on p53. This study highlights the modulation of CDC25C alternative splicing as an additional regulatory event involved in cellular response to DNA damage in breast cancer cells. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:542 / 552
页数:11
相关论文
共 50 条
[1]   Differential expression of CDC25 phosphatases splice variants in human breast cancer cells [J].
Albert, Helene ;
Santos, Susana ;
Battaglia, Eric ;
Brito, Miguel ;
Monteiro, Carolino ;
Bagrel, Denyse .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (10) :1707-1714
[2]   Cell Cycle Control by the CDC25 Phosphatases [J].
Aressy, Bernadette ;
Ducommun, Bernard .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (08) :818-824
[3]   Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? [J].
Baldin, V ;
Cans, C ;
SupertiFurga, G ;
Ducommun, B .
ONCOGENE, 1997, 14 (20) :2485-2495
[4]  
BARTEK J, 1990, ONCOGENE, V5, P893
[5]   Cellular stress and RNA splicing [J].
Biamonti, Giuseppe ;
Caceres, Javier F. .
TRENDS IN BIOCHEMICAL SCIENCES, 2009, 34 (03) :146-153
[6]   The when and wheres of CDC25 phosphatases [J].
Boutros, R ;
Dozier, C ;
Ducommun, B .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (02) :185-191
[7]   CDC25 phosphatases in cancer cells: key players? Good targets? [J].
Boutros, Rose ;
Lobjois, Valerie ;
Ducommun, Bernard .
NATURE REVIEWS CANCER, 2007, 7 (07) :495-507
[8]  
Bureik M, 2000, INT J ONCOL, V17, P1251
[9]   An emerging role for nuclear RNA-mediated responses to genotoxic stress [J].
Busa, Roberta ;
Sette, Claudio .
RNA BIOLOGY, 2010, 7 (04) :390-396
[10]   BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS [J].
CAILLEAU, R ;
YOUNG, R ;
OLIVE, M ;
REEVES, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :661-674